产品详情
-
Product Name
Anti-PD-L1 [Atezolizumab]
-
Gene ID
-
-
SwissProt ID
-
-
Gene Name
-
-
Alternative Names
Programmed cell death 1 ligand 1; Cd274; PDCD1 ligand 1; Programmed death ligand 1; B7 homolog 1; B7-H1; B7h1; Pdcd1l1; Pdcd1lg1; Pdl1; PDL-1
-
Background
Atezolizumab biosimilar is an Fc-engineered, humanized, monoclonal antibody that binds to PD-L1 and blocks interactions with the PD-1 and B7.1 receptors. Atezolizumab biosimilar is a non-glycosylated IgG1 kappa immunoglobulin that has a calculated molecular mass of 145 kDa.
-
Research Field
Epigenetics and Nuclear Signaling
-
Product Categories
Primary antibody
-
Host
Humanized
-
Reactivity
Human
-
Application
Functional Assay
-
Dilution Ratio
-
-
Molecular Weight
-
-
Clonality
Monoclonal Antibody
-
Clonality No.
-
-
Isotype
IgG1
-
Immunogen
-
-
Purification
Affinity Purified
-
Conjugation
Unconjugated
-
Modification
Unmodified
-
Form
Liquid
-
Buffer System
0.01M PBS, pH 7.2
-
Storage
This solution is stable for at least 4 weeks when stored at 2-8°C. For long term storage aseptically aliquot and store at –80°C. Avoid repeated freeze/thaw cycles.
应用缩写
WB:蛋白质印迹法IHC-P:石蜡切片样本的免疫组织化学法IHC-F:冰冻切片样本的免疫组织化学法ICC/IF:免疫细胞荧光 IP:免疫沉淀法FC:流式细胞术ChIP:染色质免疫沉淀法ELISA:酶联免疫吸附测定
正能生物产品售后保障范围仅限官网产品详情页中“应用”一栏写明的实验应用,请参照上方的缩写含义,仔细对照后选择合适的产品。